Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Antibiotic Prophylaxis in Eyelid Surgery
NCT03199911Phase 4Completed
- Sponsor
- University of California, San Francisco
- Start
- Oct 2017
- Primary completion
- Nov 2019
- Modality
- Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of erythromycin and bacitracin in surgical site infection (SSI) (2 arms), sponsored by University of California, San Francisco. Primary endpoint: Number of Participants With Surgical Site Infections. Started Oct 2017; status: completed.
02
Drugs
erythromycinbacitracin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT03199911.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03199911.